Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59.6M
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
37.2M
-
Shares change
-
+575K
-
Total reported value, excl. options
-
$186M
-
Value change
-
+$2.53M
-
Put/Call ratio
-
0.67
-
Number of buys
-
58
-
Number of sells
-
-37
-
Price
-
$4.99
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2024
140 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.2M shares
of 59.6M outstanding shares and own 62.4% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (9.28M shares), Knoll Capital Management, LLC (5.48M shares), BlackRock, Inc. (3.79M shares), VANGUARD GROUP INC (3.76M shares), KENNEDY CAPITAL MANAGEMENT LLC (1.47M shares), ARDSLEY ADVISORY PARTNERS LP (1.15M shares), GEODE CAPITAL MANAGEMENT, LLC (1.12M shares), STATE STREET CORP (1.03M shares), DIMENSIONAL FUND ADVISORS LP (736K shares), and RAYMOND JAMES FINANCIAL INC (727K shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.